Basic information Safety Supplier Related

Ethyl 8-Methyl-1,4-dioxa-spiro[4,5]decane-8-carboxylate

Basic information Safety Supplier Related

Ethyl 8-Methyl-1,4-dioxa-spiro[4,5]decane-8-carboxylate Basic information

Product Name:
Ethyl 8-Methyl-1,4-dioxa-spiro[4,5]decane-8-carboxylate
Synonyms:
  • Ethyl 8-Methyl-1,4-dioxa-spiro[4,5]decane-8-carboxylate
  • 1,4-Dioxaspiro[4.5]decane-8-carboxylic acid, 8-methyl-, ethyl ester
CAS:
24730-88-9
MF:
C12H20O4
MW:
228.28
Mol File:
24730-88-9.mol
More
Less

Ethyl 8-Methyl-1,4-dioxa-spiro[4,5]decane-8-carboxylate Chemical Properties

Boiling point:
297.0±40.0 °C(Predicted)
Density 
1.10±0.1 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
Appearance
Light yellow to yellow Liquid
More
Less

Ethyl 8-Methyl-1,4-dioxa-spiro[4,5]decane-8-carboxylate Usage And Synthesis

Synthesis

1489-97-0

74-88-4

24730-88-9

Ethyl 8-methyl-1,4-dioxaspiro[4.5]decane-8-carboxylate was synthesized as follows: n-butyllithium (n-BuLi, 1.6 eq.) was added slowly and dropwise to an anhydrous THF (1 M) solution of diisopropylamine (DIA, 1.2 eq.) over 20 min at 0 °C. The reaction mixture was stirred at 0 °C for 30 min and further cooled to -78 °C. Subsequently, a solution of ethyl 1,4-dioxaspiro[4.5]decane-8-carboxylate (1 eq.) in THF (1 M) was added slowly and dropwise over 30 minutes, followed by the addition of iodomethane (3 eq.). The reaction mixture was stirred at room temperature overnight. After completion of the reaction, the reaction mixture was diluted with brine and extracted with ethyl acetate. The organic layers were combined, washed with brine, dried over anhydrous sodium sulfate (Na2SO4) and filtered. The filtrate was concentrated to afford the target product ethyl 8-methyl-1,4-dioxaspiro[4.5]decane-8-carboxylate in 100% yield. The product was characterized by 1H NMR (400 MHz, CDCl3) with the following chemical shifts δ (ppm): 4.16 (q, J=7.1 Hz, 2H), 3.95 (s, 4H), 2.19-2.11 (m, 2H), 1.72-1.57 (m, 4H), 1.57-1.45 (m, 2H), 1.30-1.24 (m, 3H ), 1.20 (s, 3H).

References

[1] Patent: US2016/96841, 2016, A1. Location in patent: Paragraph 0332
[2] Patent: WO2018/13486, 2018, A1. Location in patent: Page/Page column 19
[3] Patent: US2009/253677, 2009, A1. Location in patent: Page/Page column 70
[4] Patent: CN105566324, 2016, A. Location in patent: Paragraph 0337; 0338; 0339; 0340
[5] Patent: US2009/275574, 2009, A1. Location in patent: Page/Page column 21

Ethyl 8-Methyl-1,4-dioxa-spiro[4,5]decane-8-carboxylateSupplier

PharmaBlock Sciences (Nanjing),Inc.
Tel
025-86918202 4000255188
Email
sales@pharmablock.com
Tetranov Biopharm
Tel
13526569071
Email
sales@leadmedpharm.com
Shanghai Topbiochem Technology Co., Ltd
Tel
021-58170097
Email
info@topbiochem.com
Suzhou Sino Rare Chemical Co., Ltd.
Tel
0512-62857507
Email
sales@sinorarechem.com
Bide Pharmatech Ltd.
Tel
400-164-7117 13681763483
Email
product02@bidepharm.com